pharmaceutical investing Advanced Proteome Therapeutics Announces Progress on Antibody-Radioisotope Conjugate Initiative
Ni-Co Energy Reports 4.60 Metres at 0.59% Nickel at Kremer-2; Phase-One Drilling Advances Magmatic Sulphide Exploration Model